These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11911552)

  • 1. Dosing and switching strategies for quetiapine fumarate.
    Cutler AJ; Goldstein JM; Tumas JA
    Clin Ther; 2002 Feb; 24(2):209-22. PubMed ID: 11911552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from other antipsychotics to once-daily extended release quetiapine fumarate in patients with schizophrenia.
    Ganesan S; Agambaram V; Randeree F; Eggens I; Huizar K; Meulien D;
    Curr Med Res Opin; 2008 Jan; 24(1):21-32. PubMed ID: 18021496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia.
    King DJ; Link CG; Kowalcyk B
    Psychopharmacology (Berl); 1998 May; 137(2):139-46. PubMed ID: 9630000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
    Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
    Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
    J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid versus conventional initiation of quetiapine in the treatment of schizophrenia: a randomized, parallel-group trial.
    Pae CU; Kim JJ; Lee CU; Lee SJ; Lee C; Patkar AA; Masand PS; Paik IH
    J Clin Psychiatry; 2007 Mar; 68(3):399-405. PubMed ID: 17388709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.
    Pan PY; Lee MS; Yeh CB
    BMC Psychiatry; 2015 Jan; 15():1. PubMed ID: 25609320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.
    Potkin SG; Thyrum PT; Alva G; Carreon D; Yeh C; Kalali A; Arvanitis LA;
    J Clin Psychopharmacol; 2002 Apr; 22(2):174-82. PubMed ID: 11910263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Administration of once-daily extended release quetiapine in schizophrenic disorders].
    Bartkó G
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):189-95. PubMed ID: 18510263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
    Tauscher-Wisniewski S; Kapur S; Tauscher J; Jones C; Daskalakis ZJ; Papatheodorou G; Epstein I; Christensen BK; Zipursky RB
    J Clin Psychiatry; 2002 Nov; 63(11):992-7. PubMed ID: 12444812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
    Mullen J; Jibson MD; Sweitzer D
    Clin Ther; 2001 Nov; 23(11):1839-54. PubMed ID: 11768836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High degree of tolerability for monotherapy with high doses of quetiapine: a case report.
    Bobes J; Garcia-Portilla MP; Saiz PA; Bascaran MT; Bousoño M; Arango C
    J Clin Psychiatry; 2002 Nov; 63(11):1048-9. PubMed ID: 12469690
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid dose escalation with quetiapine: a pilot study.
    Smith MA; McCoy R; Hamer-Maansson J; Brecher M
    J Clin Psychopharmacol; 2005 Aug; 25(4):331-5. PubMed ID: 16012275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
    McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
    J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A random-assignment, double-blind, clinical trial of once- vs twice-daily administration of quetiapine fumarate in patients with schizophrenia or schizoaffective disorder: a pilot study.
    Chengappa KN; Parepally H; Brar JS; Mullen J; Shilling A; Goldstein JM
    Can J Psychiatry; 2003 Apr; 48(3):187-94. PubMed ID: 12728743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies.
    Citrome L; Jaffe A; Levine J; Lindenmayer JP
    J Clin Psychiatry; 2005 Dec; 66(12):1512-6. PubMed ID: 16401150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.